Clinical Trials Directory

Trials / Completed

CompletedNCT03484546

Optimum Menstrual Cycle Time for Endometrioma Excision

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Acibadem University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the optimum day of menstrual period for the excision of endometriomas to minimize the damage of surgery to normal ovarian tissue. Patients will be grouped as follicular, ovulatory and luteal according to menstrual days. Ovarian damage will be evaluated with both pathologic examination and anti-mullerian hormone levels before and after the surgery.

Detailed description

Endometriosis is a common gynecologic disease seen in about 10% of women in reproductive age. The most common site of endometriosis is overt. Cystic formation of ovarian endometriosis is called endometrioma (chocolate cyst). Definitive treatment of endometriomas is excision by laparoscopy. The disadvantage of this surgery is the removal of some of the normal ovarian follicles within cystectomy material. This procedure can damage the ovarian reserves with the treatment of endometriomas, which are already the cause of infertility, and lead to the conditions such as infertility or early menopause. It has been understood that the ovarian reserves of the patients who underwent endometrioma cystectomy with the decrease of the Anti-Mullerian Hormone values, which is an over reserve parameter.

Conditions

Interventions

TypeNameDescription
PROCEDURElaparoscopic endometrioma cyst excisionlaparoscopic resection of ovarian endometrioma

Timeline

Start date
2018-03-26
Primary completion
2021-10-01
Completion
2021-10-01
First posted
2018-04-02
Last updated
2023-10-24

Locations

3 sites across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03484546. Inclusion in this directory is not an endorsement.